Patient enrollment ongoing in phase II study of M-1095 in chronic plaque-type psoriasis Sep. 26, 2018
Phase II results presented for BMS-986165 in patients with moderate to severe psoriasis Sep. 19, 2018
Ilumetri receives approval in Europe for treatment of moderate to severe chronic plaque psoriasis Sep. 19, 2018
RSS